Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Medtronic
Mallinckrodt
Daiichi Sankyo
McKesson
Cipla
Accenture
US Army
US Department of Justice

Generated: November 13, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019814

« Back to Dashboard

NDA 019814 describes BETAGAN, which is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. Additional details are available on the BETAGAN profile page.

The generic ingredient in BETAGAN is levobunolol hydrochloride. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for 019814
Tradename:BETAGAN
Applicant:Allergan
Ingredient:levobunolol hydrochloride
Patents:0
Medical Subject Heading (MeSH) Categories for 019814

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.25%
Approval Date:Jun 28, 1989TE:ATRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cerilliant
Fuji
Teva
Express Scripts
Chubb
Cipla
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.